Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)

  title={Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19)},
  author={L{\'a}szl{\'o} Instit{\'o}ris and Katalin Kov{\'a}cs and {\'E}va Sija and R{\'o}bert Berkecz and T{\'i}mea K{\"o}rm{\"o}czi and Istv{\'a}n N{\'e}meth and Istvan Elek and {\'A}gnes Bakos and Ildik{\'o} Urb{\'a}n and Csaba Pap and {\'E}va Margit Kereszty},
  journal={Clinical Toxicology},
  pages={18 - 24}
Abstract Background New Psychoactive Substances (NPS) impose a new challenge on the legal and health care system, yet, there is little information available about how new substances spread based on hospitalization of intoxicated patients. The aims of this study were: (i) to investigate the frequency of NPS among suspected drug intoxicated patients, (ii) to study the connection between blood concentration and clinical symptoms, (iii) to determine their half-life with a time-series blood sampling… 
Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review
The objective of this study was to determine the best human biological matrices to detect the risk-assessed compounds provided by The European Monitoring Centre for Drugs and Drug Addiction: AB-CHMINACA, ADB-CHMNACA, MDMB-CHMICA, and 5F-MDMB-PINACA.


Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA
The valine derivative AB-CHMINACA and the tert-leucine derivative MDMB-CHMICA (“third generation of SCs”) seem to be associated with more severe clinical toxicity than was previously reported in patients exposed to earlier generation SCs such as JWH-018.
Blood concentrations of synthetic cannabinoids
The observed concentrations of SCs vary widely and often have overlapping ranges for fatal and non-fatal cases, therefore, a referenced compilation of concentration ranges would be useful.
Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine and Blood Samples
The main phase I metabolites of 4F-MDMD-BICA were successfully characterized, and the routine analytical method with related sample preparation procedure provided a reliable analytical tool for screening both 4F and its selected metabolites in urine and blood samples.
Stability of Synthetic Cathinones in Blood.
The objective of this study was to systematically evaluate the concentration, temperature and analyte-dependent stability of synthetic cathinones in preserved blood using liquid-chromatography/quadrupole-time of flight-mass spectrometry (LC/Q-TOF-MS).
Designer drugs: mechanism of action and adverse effects
Because of their novelty, designer drugs may remain undetected by routine drug screening, thus hampering evaluations of adverse effects.
[Driving under the influence of drugs].
  • S. Ferrara
  • Medicine
    Zeitschrift fur Allgemeinmedizin
  • 1972
The number of drug users has been increasing over years, and risk assessment and prevention of drug-related vehicle use are becoming increasingly important.
Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
It is shown that Δ9-tetrahydrocannabinol (Δ9-THC), the main active compound in marijuana, reduces neuronal injury in neonatal rats injected intracerebrally with the Na+/K+-ATPase inhibitor ouabain to elicit excitotoxicity.
Focus on cannabinoids and synthetic cannabinoids
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state‐of‐the‐art on lato sensu cannabinoids. By modulating